Literature DB >> 23880135

Colonic bacterial metabolites and human health.

Wendy R Russell1, Lesley Hoyles, Harry J Flint, Marc-Emmanuel Dumas.   

Abstract

The influence of the microbial-mammalian metabolic axis is becoming increasingly important for human health. Bacterial fermentation of carbohydrates (CHOs) and proteins produces short-chain fatty acids (SCFA) and a range of other metabolites including those from aromatic amino acid (AAA) fermentation. SCFA influence host health as energy sources and via multiple signalling mechanisms. Bacterial transformation of fibre-related phytochemicals is associated with a reduced incidence of several chronic diseases. The 'gut-liver axis' is an emerging area of study. Microbial deconjugation of xenobiotics and release of aromatic moieties into the colon can have a wide range of physiological consequences. In addition, the role of the gut microbiota in choline deficiency in non-alcoholic fatty liver disease (NAFLD) and insulin resistance is receiving increased attention.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23880135     DOI: 10.1016/j.mib.2013.07.002

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  108 in total

1.  Editorial on "Cancer and the microbiota" published in Science.

Authors:  Alison K Hamm; Tiffany L Weir
Journal:  Ann Transl Med       Date:  2015-08

Review 2.  Xenobiotics: Interaction with the Intestinal Microflora.

Authors:  Kun Lu; Ridwan Mahbub; James G Fox
Journal:  ILAR J       Date:  2015

3.  Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates.

Authors:  Erica D Sonnenburg; Justin L Sonnenburg
Journal:  Cell Metab       Date:  2014-08-21       Impact factor: 27.287

4.  Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis.

Authors:  Georg Schneditz; Jana Rentner; Sandro Roier; Jakob Pletz; Kathrin A T Herzog; Roland Bücker; Hanno Troeger; Stefan Schild; Hansjörg Weber; Rolf Breinbauer; Gregor Gorkiewicz; Christoph Högenauer; Ellen L Zechner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

5.  Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men.

Authors:  Anne Salonen; Leo Lahti; Jarkko Salojärvi; Grietje Holtrop; Katri Korpela; Sylvia H Duncan; Priya Date; Freda Farquharson; Alexandra M Johnstone; Gerald E Lobley; Petra Louis; Harry J Flint; Willem M de Vos
Journal:  ISME J       Date:  2014-04-24       Impact factor: 10.302

Review 6.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

Review 7.  The gut microbiota, bacterial metabolites and colorectal cancer.

Authors:  Petra Louis; Georgina L Hold; Harry J Flint
Journal:  Nat Rev Microbiol       Date:  2014-09-08       Impact factor: 60.633

8.  The "metabolic winter" hypothesis: a cause of the current epidemics of obesity and cardiometabolic disease.

Authors:  Raymond J Cronise; David A Sinclair; Andrew A Bremer
Journal:  Metab Syndr Relat Disord       Date:  2014-06-11       Impact factor: 1.894

Review 9.  Gut Microbiome in Chronic Kidney Disease.

Authors:  R G Armani; A Ramezani; A Yasir; S Sharama; M E F Canziani; D S Raj
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

10.  Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut.

Authors:  Henrik M Roager; Lea B S Hansen; Martin I Bahl; Henrik L Frandsen; Vera Carvalho; Rikke J Gøbel; Marlene D Dalgaard; Damian R Plichta; Morten H Sparholt; Henrik Vestergaard; Torben Hansen; Thomas Sicheritz-Pontén; H Bjørn Nielsen; Oluf Pedersen; Lotte Lauritzen; Mette Kristensen; Ramneek Gupta; Tine R Licht
Journal:  Nat Microbiol       Date:  2016-06-27       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.